Brief: Exact Therapeutics H1 Net Loss Narrows To NOK 22.8 Mln

Exact Therapeutics AS

28/09/2023 07:11

Sept 28 (Reuters) - Exact Therapeutics AS  EXTX.OL :
    * TOTAL OPERATING EXPENSES FOR THE FIRST HALF OF 2023 CAME
TO NOK
22.3 MILLION (H1 2022 NOK 26.3 MILLION)
    * NET RESULT FOR FIRST HALF OF 2023 WAS NOK -22.8 MILLION
(H1 2022
NOK -26.3 MILLION)

Source text for Eikon:  ID:nObi2Kc03a 
Further company coverage:  EXTX.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))